» Articles » PMID: 6403323

[Doppler Ultrasound Studies of the Extracranial Cerebral Vessels in Migraine Patients After Ergotamine Tartrate Administration]

Overview
Date 1983 Mar 25
PMID 6403323
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Doppler ultrasound investigations were done in 20 patients with migraine during the symptom-free interval after oral administration of 2 mg and 6 mg ergotamine tartrate. The observed changes of end-diastolic flow velocity as a measure of peripheral total resistance permit simultaneous assessment of the vasoconstrictor effect of ergotamine in the perfusion area of the internal and external carotid arteries. A dosage of 2 mg led to an exclusive increase of resistance in the external carotid artery area without significant changes in the internal carotid area. A maximal therapeutic dosage of 6 mg ergotamine tartrate did not lead to a significant increase of the vasoconstrictor effect in the external carotid circulation. In addition, a barely registrable increase of resistance in the internal carotid area could now be observed.

Citing Articles

Clinical pharmacokinetics of ergotamine in migraine and cluster headache.

Perrin V Clin Pharmacokinet. 1985; 10(4):334-52.

PMID: 3899452 DOI: 10.2165/00003088-198510040-00004.


Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors.

Bom A, Heiligers J, Saxena P, Verdouw P Br J Pharmacol. 1989; 97(2):383-90.

PMID: 2758221 PMC: 1854530. DOI: 10.1111/j.1476-5381.1989.tb11965.x.


Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs.

Diener H, Peters C, Rudzio M, Noe A, Dichgans J, Haux R J Neurol. 1991; 238(5):245-50.

PMID: 1655985 DOI: 10.1007/BF00319734.


Pharmacology of antimigraine drugs.

Saxena P, Den Boer M J Neurol. 1991; 238 Suppl 1:S28-35.

PMID: 1646288 DOI: 10.1007/BF01642903.